Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to multiple distinct proteins frequently associated with cellular stress responses, immunogenic cell death signals, and tumor immunity regulation, including heat shock proteins 70/90, calreticulin, nucleolin, S100A8, and HMGB1. Each plays unique roles in cancer biology—such as promoting tumor survival under stress conditions or acting as DAMPs that stimulate anti-tumor immunity—but they do not form a single molecular complex nor share an identical therapeutic targeting strategy. The grouping is commonly used when discussing immunogenic features of dying cells but should be split into individual targets for structured data extraction purposes[1][5].
Drugs typically act by inhibiting the chaperone activity of heat shock proteins or modulating their release/function as damage-associated molecular patterns (DAMPs), thereby affecting tumor cell survival or immune activation[1].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on null.